After a washed-out year, beer makers bet big on summer for FY27 growth
Early summer and state reforms are boosting sales, pointing to a rebound in India’s beer market in FY27. Supply bottlenecks and weather risks could temper the upturn.
Semaglutide’s patent expired on Friday, and several top Indian drugmakers will launch cheaper generics immediately, with intense competition expected.
A dedicated blog writer with a passion for capturing the pulse of viral news, Vimal covers a diverse range of topics, including international and national affairs, business trends, cryptocurrency, and technological advancements. Known for delivering timely and compelling content, this writer brings a sharp perspective and a commitment to keeping readers informed and engaged.